Skip to main content

Point/counterpoint: we do not need randomized clinical trials to demonstrate the superiority of proton therapy.

Publication ,  Journal Article
Sakurai, H; Robert Lee, W; Orton, CG
Published in: Med Phys
April 2012

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

April 2012

Volume

39

Issue

4

Start / End Page

1685 / 1687

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Radiotherapy, High-Energy
  • Proton Therapy
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Humans
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • 5105 Medical and biological physics
  • 4003 Biomedical engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sakurai, H., Robert Lee, W., & Orton, C. G. (2012). Point/counterpoint: we do not need randomized clinical trials to demonstrate the superiority of proton therapy. Med Phys, 39(4), 1685–1687. https://doi.org/10.1118/1.3681013
Sakurai, Hideyuki, W. Robert Lee, and Colin G. Orton. “Point/counterpoint: we do not need randomized clinical trials to demonstrate the superiority of proton therapy.Med Phys 39, no. 4 (April 2012): 1685–87. https://doi.org/10.1118/1.3681013.
Sakurai, Hideyuki, et al. “Point/counterpoint: we do not need randomized clinical trials to demonstrate the superiority of proton therapy.Med Phys, vol. 39, no. 4, Apr. 2012, pp. 1685–87. Pubmed, doi:10.1118/1.3681013.

Published In

Med Phys

DOI

ISSN

0094-2405

Publication Date

April 2012

Volume

39

Issue

4

Start / End Page

1685 / 1687

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Radiotherapy, High-Energy
  • Proton Therapy
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Humans
  • Evidence-Based Medicine
  • Clinical Trials as Topic
  • 5105 Medical and biological physics
  • 4003 Biomedical engineering